High-dose IgG treatment for neonatal alloimmune thrombocytopenia
Clicks: 149
ID: 261523
1970
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
149 views
36 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #43 of 99 articles by views in blut
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Twelve children with neonatal alloimmune thrombocytopenia (NAT) due to Zwa incompatibility were treated with intravenous IgG (IVIG). Total doses ranged between 1 and 9 g. Ten out of 12 infants had a favorable response. It is concluded that IVIG can serve as an emergency treatment in NAT if material (or compatible) platelets are not available.
| Reference Key |
mueller-eckhardt1970bluthigh-dose
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Christian Mueller-Eckhardt;Volker Kiefel;Alfons Grubert;Christian Mueller-Eckhardt;Volker Kiefel;Alfons Grubert; |
| Journal | blut |
| Year | 1970 |
| DOI |
doi:10.1007/BF00320268
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.